-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M4l2Ug5gOlBUTHtCKJl9jMZb8fILdrcUlJ6jWmxHbqtlxIR68y6ZdTE2S09SZBo+ WlBmUp7kVGq/DeiqQxqyOQ== 0000950116-96-000673.txt : 19960724 0000950116-96-000673.hdr.sgml : 19960724 ACCESSION NUMBER: 0000950116-96-000673 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960723 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GERIATRIC & MEDICAL COMPANIES INC CENTRAL INDEX KEY: 0000041147 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 231713341 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-03997 FILM NUMBER: 96597499 BUSINESS ADDRESS: STREET 1: 5601 CHESTNUT ST CITY: PHILADELPHIA STATE: PA ZIP: 19139 BUSINESS PHONE: 2154762250 MAIL ADDRESS: STREET 1: 5601 CHESTNUT ST CITY: PHILADELPHIA STATE: PA ZIP: 19139 FORMER COMPANY: FORMER CONFORMED NAME: GERIATRIC & MEDICAL CENTERS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: RUPUBLIC GYPSUM CO DATE OF NAME CHANGE: 19711121 COMPANY DATA: COMPANY CONFORMED NAME: GENESIS HEALTH VENTURES INC /PA CENTRAL INDEX KEY: 0000874265 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] OWNER IRS NUMBER: 061132947 STATE OF INCORPORATION: PA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 148 W STATE ST STE 100 CITY: KENNETT SQUARE STATE: PA ZIP: 19348 BUSINESS PHONE: 6104446350 MAIL ADDRESS: STREET 1: 148 W STATE STREET CITY: KENNETT SQUARE STATE: PA ZIP: 19348 3 1 - ------ ------------------------------------ FORM 3 OMB APPROVAL - ------ ------------------------------------ OMB Number 3235-0104 Expires: February 1, 1994 Estimated average burden hours per response .............0.5 ------------------------------------ U. S. SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 INITITAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - ------------------------------------------------------------------------------- 1. Name and Address of Reporting Person Genesis Health Ventures, Inc. -------------------------------------------------------------------- (Last) (First) (MI) 148 West State Street -------------------------------------------------------------------- (Street) Kennett Square PA 19148 -------------------------------------------------------------------- (City) (State) (Zip) 2. Date of Event Requiring Statement (Month/Day/Year) 7/11/96 - ------------------------------------------------------------------------------- 3. IRS or Social Security Number of Reporting Person (Voluntary) 06-1132947 - ------------------------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol Geriatric & Medical Companies, Inc. (GEMC) - ------------------------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [ X ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) --------------------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) - ------------------------------------------------------------------------------- TABLE I - Non-Derivative Securities Beneficially Owned - -------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 2. Amount of Securities | 3. Ownership Form: | 4. Nature of Indirect Beneficial (Instr. 4) | Beneficially Owned | Direct (D) or Indirect | Ownership (Instr. 5) | (Instr. 4) | (I) (Instr. 5) | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - -----------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a seperate line for each class of securities beneficially owned directly or indirectly. (Print or Type Responses) (Over) SEC 1473 (3/91)
FORM 3 (continued) Table II -- Derivative Securities Benefically Owned (e.g., puts, calls, warrants, options, convertible securities) - --------------------------------------------------------------------------------------------- 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date | (Month/Day/Year) |----------------------------------------- | Date Exercisable | Expiration Date - --------------------------------------------------------------------------------------------- | | | | Option (1) | 7/11/96 | (1) - --------------------------------------------------------------------------------------------- | | | | | | - --------------------------------------------------------------------------------------------- | | | | | | - --------------------------------------------------------------------------------------------- | | | | | | ============================================================================================= =================================================================================================================================== 3. Title and Amount of Securities | 4. Conversion or Exercise | 5. Ownership Form of Derivative | 6. Nature of Indirect Underlying Derivative Security | Price of Derivative | Security: Direct (D) or | Beneficial Ownership (Instr. 4) | Security | Indirect (I) (Instr. 5) | (Instr. 5) - -----------------------------------------| | | | Ammount or | | | | Number of | | | Title | Shares | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | Common Stock | 3,748,178 | $5.75(1) | I | 1 - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934 (as amended), the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person. (1) See attached supplement. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. GENESIS HEALTH VENTURES, INC. By: /s/ George V. Hager, Jr. July 22, 1996 ---------------------------- ------------- **Signature of Reporting Person Date George V. Hager, Jr. Senior Vice President and Chief Financial Officer Page 2 SEC 1473 (3/91) (1) This statement relates to a Stockholder Option and Proxy Agreement dated as of July 11, 1996 (the "Agreement") among G Acquisition Corporation ("Newco"), a wholly owned subsidiary of Genesis Health Ventures, Inc. ("Genesis"), Tomahawk Holdings, Inc. ("Shareholder"), Tomahawk Capital Holdings, Inc. and Daniel Veloric (Shareholder, Tomahawk Capital Holdings, Inc. and Daniel Veloric are referred to collectively herein as the "Owners") pursuant to which Owners granted to Newco (i) an option (the "Stock Option") to purchase the shares (the "Shares") of Geriatric & Medical Companies, Inc. ("Issuer") owned by Shareholder and (ii) an irrevocable proxy (the "Proxy") both as more fully described below. The Stock Option entitles Newco to purchase the Shares owned by the Shareholder for a purchase price (the "Exercise Price") of $5.75 per Share. The Agreement was entered into to induce Genesis and Newco to enter into an Agreement and Plan of Merger dated July 11, 1996 among Newco, Genesis and Issuer (the "Merger Agreement") pursuant to which Newco has agreed, subject to certain conditions, to merge into GMC (the "Merger"). The Option may be exercised by Newco, in whole or in part, at any time prior to the earlier of (i) the day following the effective date of the Merger or (ii) (A) one year after the termination of the Merger Agreement, if the Merger is not approved by a vote of over 50% of the shares of the Issuer or if the Merger Agreement is terminated after the Issuer has willfully taken actions or willfully failed to take actions which cause a default under the Merger Agreement or a condition to Genesis's consummation of the Merger Agreement not to be met; (B) six months after termination of an unsuccessful proposed third party acquisition if the Merger Agreement had been terminated under the Merger Agreement as a result of a proposed third party acquisition; (C) immediately if the Merger Agreement is terminated upon a default by Genesis; and (D) three months after the termination of the Merger Agreement if the Merger Agreement is terminated for any other reason. In the event that at any time prior to the effective date of the Merger the highest price paid by Newco for any share of Issuer Common Stock exceeds $5.75 (as adjusted) then (a) the Exercise Price shall be adjusted to the highest such price, and (b) as to Shares as to which the Option has previously been exercised, Newco or Genesis shall promptly pay the amount of the product of (i) the amount of such excess price per share, multiplied by (ii) the number of Shares as to which the Option has previously been exercised. If, after Newco has exercised the Option and prior to the consummation of the Merger, Newco directly or indirectly sells or otherwise disposes of any Shares purchased pursuant to the Option (other than in the Merger or to Genesis) then Newco or Genesis shall pay to the Shareholder, as promptly as practicable after such sale or other disposition, the amount on a per share basis, if any, by which the net proceeds received by Newco upon the sale or other disposition exceeds the aggregate price paid by Newco to the Shareholder upon exercise of the Option for the purchase of such Share. Under the Agreement, the Owners agree to vote (or cause to be voted) the Shares owned by them in any circumstance in which the vote or approval of the shareholders of the Issuer is sought (i) in favor of adoption and approval of the Merger Agreement and the Merger and the terms thereof and each of the other actions contemplated by the Merger Agreement and the Agreement; (ii) against any action or agreement that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Issuer contained in the Merger Agreement or of any Shareholder in this Agreement; and (iii) against any action, agreement or transaction that is intended or could reasonably be expected to facilitate a person other than Newco or its affiliate in acquiring control of the Issuer or any other action, agreement or transaction (other than the Merger Agreement or the transactions contemplated thereby) that is intended, or could reasonably be expected to impede, interfere or be inconsistent with, delay, postpone, discourage or materially adversely affect the consummation of the Merger or the performance by the parties hereto of their respective obligations under this Agreement. Under the Agreement, the Shareholder irrevocably granted to Newco and appointed Newco (with full power of substitution) its proxy to vote the Shares owned by it in the manner described in the preceding paragraph. Pursuant to the Agreement, the Owners, until the earlier to occur of (a) termination of the Merger Agreement and (b) the effective date of the Merger, shall not transfer any of its Shares or any interests therein, except pursuant to the Merger (other than, under limited circumstances, certain security interests in the Shares). -----END PRIVACY-ENHANCED MESSAGE-----